Abstract:RNA editing offers the opportunity to introduce either stable or transient modifications to nucleic acid sequence without permanent off-target effects, but installation of arbitrary edits into the transcriptome is currently infeasible. Here, we describe Programmable RNA Editing & Cleavage for Insertion, Substitution, and Erasure (PRECISE), a versatile RNA editing method for writing RNA of arbitrary length and sequence into existing pre-mRNAs via 5′ or 3′ trans-splicing. In trans-splicing, an exogenous template is introduced to compete with the endogenous pre-mRNA, allowing for replacement of upstream or downstream exon sequence. Using Cas7-11 cleavage of pre-mRNAs to bias towards editing outcomes, we boost the efficiency of RNA trans-splicing by 10–100 fold, achieving editing rates between 5–50% and 85% on endogenous and reporter transcripts, respectively, while maintaining high-fidelity. We demonstrate PRECISE editing across 11 distinct endogenous transcripts of widely varying expression levels, showcasing more than 50 types of edits, including all 12 possible transversions and transitions, insertions ranging from 1 to 1,863 nucleotides, and deletions. We show high efficiency replacement of exon 4 of MECP2, addressing most mutations that drive the Rett Syndrome; editing of SHANK3 transcripts, a gene involved in Autism; and replacement of exon 1 of HTT, removing the hallmark repeat expansions of Huntington′s disease. Whole transcriptome sequencing reveals the high precision of PRECISE editing and lack of off-target trans-splicing activity. Furthermore, we combine payload engineering and ribozymes for protein-free, high-efficiency trans-splicing, with demonstrated efficiency in editing HTT exon 1 via AAV delivery. We show that the high activity of PRECISE editing enables editing in non-dividing neurons and patient-derived Huntington’s disease fibroblasts. PRECISE editing markedly broadens the scope of genetic editing, is straightforward to deliver over existing gene editing tools like prime editing, lacks permanent off-targets, and can enable any type of genetic edit large or small, including edits not otherwise possible with existing RNA base editors, widening the spectrum of addressable diseases.

RNA editing with CRISPR-Cas13

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

A cytosine deaminase for programmable single-base RNA editing

A circularly permuted CasRx platform for efficient, site-specific RNA editing

CRISPR-Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family

Programmable RNA base editing with photoactivatable CRISPR-Cas13

RNA editing with CRISPR

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Programmable RNA base editing via targeted modifications

Precision RNA base editing with engineered and endogenous effectors

A New RNA-Dependent Cas12g Nuclease

Programmable RNA writing with trans-splicing

Robust RNA editing via recruitment of endogenous ADARs using circular guide RNAs

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Implementation of the CRISPR-Cas13a system in fission yeast and its repurposing for precise RNA editing.

Harnessing RNA-based DNA repair pathways for targeted gene editing

Non-viral Delivery of CRISPR–Cas9 Complexes for Targeted Gene Editing Via a Polymer Delivery System

Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e